Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Zimmer Biomet Holdings (ZBH)

Zimmer Biomet Holdings (ZBH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 18,450,744
  • Shares Outstanding, K 198,182
  • Annual Sales, $ 7,679 M
  • Annual Income, $ 903,700 K
  • EBIT $ 1,978 M
  • EBITDA $ 2,975 M
  • 60-Month Beta 0.61
  • Price/Sales 2.43
  • Price/Cash Flow 7.14
  • Price/Book 1.46

Options Overview Details

View History
  • Implied Volatility 24.83% (-1.31%)
  • Historical Volatility 52.62%
  • IV Percentile 35%
  • IV Rank 19.32%
  • IV High 48.79% on 04/08/25
  • IV Low 19.09% on 02/06/25
  • Expected Move (DTE 15) 3.80 (4.08%)
  • Put/Call Vol Ratio 3.18
  • Today's Volume 347
  • Volume Avg (30-Day) 623
  • Put/Call OI Ratio 1.11
  • Today's Open Interest 12,276
  • Open Int (30-Day) 13,266
  • Expected Range 89.36 to 96.96

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 26 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 2.38
  • Number of Estimates 10
  • High Estimate 2.43
  • Low Estimate 2.35
  • Prior Year 2.31
  • Growth Rate Est. (year over year) +3.03%

Price Performance

See More
Period Period Low Period High Performance
1-Month
85.33 +9.18%
on 11/06/25
98.34 -5.27%
on 11/28/25
-10.02 (-9.71%)
since 11/04/25
3-Month
85.33 +9.18%
on 11/06/25
106.88 -12.84%
on 10/22/25
-11.60 (-11.07%)
since 09/04/25
52-Week
85.33 +9.18%
on 11/06/25
114.44 -18.59%
on 04/03/25
-17.46 (-15.78%)
since 12/04/24

Most Recent Stories

More News
Zimmer Biomet, Cigna, Universal Health Services, Henry Schein, and Sotera Health Company Shares Skyrocket, What You Need To Know

Zimmer Biomet, Cigna, Universal Health Services, Henry Schein, and Sotera Health Company Shares Skyrocket, What You Need To Know

ZBH : 93.16 (+0.06%)
UHS : 230.59 (+0.19%)
HSIC : 73.34 (+0.63%)
CI : 268.42 (-0.15%)
SHC : 16.56 (-1.66%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zimmer Biomet Holdings, Inc. - ZBH

NEW YORK , Nov. 20, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Zimmer Biomet Holdings, Inc. ("Zimmer Biomet" or the "Company") (NYSE: ZBH). Such investors...

ZBH : 93.16 (+0.06%)
Zimmer Biomet Holdings (ZBH) Faces Investor Scrutiny Amid Emerging Markets Distributor Orders Cancelation, Reduced Top-Line Revenue Forecast -- Hagens Berman

SAN FRANCISCO , Nov. 18, 2025 /PRNewswire/ -- On November 5, 2025, investors in Zimmer Biomet Holdings, Inc. (NYSE: ZBH) saw the price of their shares tumble $15.63 (-15%) after the company announced...

ZBH : 93.16 (+0.06%)
Zimmer Biomet Receives U.S. FDA Clearance for Enhanced Version of ROSA® Knee Robotic Technology

ROSA ® Knee with OptimiZe ™ Offers Personalized Surgical Planning and Drives Confidence in Delivering Accurate and Reproducible Outcomes 1

ZBH : 93.16 (+0.06%)
Zimmer Biomet Holdings, Inc. (ZBH) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

Law Offices of Howard G. Smith announces an investigation on behalf of Zimmer Biomet Holdings, Inc. (“Zimmer” or the “Company”) (NYSE: ZBH ) investors concerning the Company’s...

ZBH : 93.16 (+0.06%)
Securities Fraud Investigation Into Zimmer Biomet Holdings, Inc. (ZBH) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm

Glancy Prongay & Murray LLP , a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Zimmer Biomet Holdings, Inc. (“Zimmer” or the...

ZBH : 93.16 (+0.06%)
Securities Fraud Investigation Into Zimmer Biomet Holdings, Inc. (ZBH) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

The Law Offices of Frank R. Cruz announces an investigation of Zimmer Biomet Holdings, Inc. (“Zimmer” or the “Company”) (NYSE: ZBH ) on behalf of investors concerning the...

ZBH : 93.16 (+0.06%)
AI Wellness Market Surges as Personalized Health Platforms Capture Investment Flow

Issued on behalf of Aleen Inc. VANCOUVER – Baystreet.ca News Commentary – AI-powered wellness platforms are commercializing rapidly as major technology companies launch personalized health...

ZBH : 93.16 (+0.06%)
CAI : 28.32 (+3.96%)
CERT : 9.57 (-1.14%)
ACN : 269.34 (-1.29%)
ALEN-U.CN : 1.3400 (unch)
Zimmer Biomet Stock: Analyst Estimates & Ratings

Zimmer Biomet has significantly underperformed the broader market and other medical device stocks over the past year, yet analysts remain optimistic about the stock’s prospects.

ZBH : 93.16 (+0.06%)
$SPX : 6,857.12 (+0.11%)
IHI : 63.31 (+0.14%)
ZBH Investor Notice: Levi & Korsinsky Investigates Zimmer Biomet Holdings, Inc. for Securities Law Violations

New York, New York--(Newsfile Corp. - November 11, 2025) - Levi & Korsinsky notifies investors that it has commenced an investigation of Zimmer Biomet Holdings, Inc. ("Zimmer Biomet Holdings, Inc.") (NYSE:...

ZBH : 93.16 (+0.06%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Zimmer Biomet is a leading musculoskeletal healthcare company that designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products....

See More

Key Turning Points

3rd Resistance Point 94.68
2nd Resistance Point 93.96
1st Resistance Point 93.56
Last Price 93.16
1st Support Level 92.45
2nd Support Level 91.73
3rd Support Level 91.33

See More

52-Week High 114.44
Fibonacci 61.8% 103.32
Fibonacci 50% 99.89
Fibonacci 38.2% 96.45
Last Price 93.16
52-Week Low 85.33

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar